MeSH Review:
Delayed Graft Function
Thervet,
Pfeffer,
Scolari,
Toselli,
Pallardó,
Chadban,
Pilmore,
Connolly,
Buchler,
Schena,
Carreño,
Dandavino,
Cole,
Keith,
DeMattos,
Golconda,
Prather,
Cantarovich,
Paraskevas,
Tchervenkov,
Norman,
Emparan,
Laukötter,
Wolters,
Dame,
Heidenreich,
Senninger,
Boschiero,
Foroni,
Tonini,
Ancona,
Kusaka,
Fukami,
Sasaki,
Higuchi,
Ishikawa,
Shiroki,
Hoshinaga,
Tanabe,
Boom,
de Heer,
van der Wal,
Kruidenier,
de Fijter,
Benediktsson,
Paul,
van Es,
Berger,
Roos,
Mallat,
Fujita,
de Fijter,
Daha,
- Calcineurin inhibitors in renal transplantation: what is the best option? Tanabe, K. Drugs (2003)
- The effects of delayed function on recipients of cadaver renal allografts. A study of 158 patients randomized to cyclosporine or ALG-azathioprine. Canafax, D.M., Torres, A., Fryd, D.S., Heil, J.E., Strand, M.H., Ascher, N.L., Payne, W.D., Sutherland, D.E., Simmons, R.L., Najarian, J.S. Transplantation (1986)
- An objective method for detecting time-dependent effects in graft survival. Boschiero, L., Foroni, R., Tonini, M., Ancona, G. Transpl. Int. (2000)
- A preliminary report of the HTK randomized multicenter study comparing kidney graft preservation with HTK and EuroCollins solutions. HTK Study Group. Groenewoud, A.F., Thorogood, J. Transpl. Int. (1992)
- Diapedesis of leukocytes: antisense oligonucleotides for rescue. Dragun, D., Haller, H. Exp. Nephrol. (1999)
- Prevention of delayed graft function in cadaver kidney transplants by diltiazem. Wagner, K., Neumayer, H.H. Lancet (1985)
- Factors associated with improvement in deceased donor renal allograft function in the 1990s. Keith, D.S., DeMattos, A., Golconda, M., Prather, J., Cantarovich, M., Paraskevas, S., Tchervenkov, J., Norman, D.J. J. Am. Soc. Nephrol. (2005)
- Addition of sirolimus to cyclosporine delays the recovery from delayed graft function but does not affect 1-year graft function. Stallone, G., Di Paolo, S., Schena, A., Infante, B., Battaglia, M., Ditonno, P., Gesualdo, L., Grandaliano, G., Schena, F.P. J. Am. Soc. Nephrol. (2004)
- The absence of delayed graft function is predicted by the presence of manganese-superoxide dismutase in distal tubules of renal allografts. Boom, H., de Heer, E., van der Wal, A., Kruidenier, L., de Fijter, J.W., Benediktsson, H., Paul, L.C., van Es, L.A. Transplantation (2005)
- HSP-72 expression in pre-transplant donor kidney biopsies and post-transplant outcome. Mueller, T., Regele, H., Posch, M., Marszalek, M., Schwarz, C., Pichlhoefer, B., Arbeiter, K., Aufricht, C. Transplantation (2004)
- Time dependency of factors affecting renal allograft survival. Prommool, S., Jhangri, G.S., Cockfield, S.M., Halloran, P.F. J. Am. Soc. Nephrol. (2000)
- Continued superior outcomes with modification and lengthened follow-up of a steroid-avoidance pilot with extended daclizumab induction in pediatric renal transplantation. Sarwal, M.M., Vidhun, J.R., Alexander, S.R., Satterwhite, T., Millan, M., Salvatierra, O. Transplantation (2003)
- A calcineurin antagonist-free induction strategy for immunosuppression in cadaveric kidney transplant recipients at risk for delayed graft function. Hong, J.C., Kahan, B.D. Transplantation (2001)
- Clinical outcomes during the first three months posttransplant in renal allograft recipients managed by C2 monitoring of cyclosporine microemulsion. Thervet, E., Pfeffer, P., Scolari, M.P., Toselli, L., Pallardó, L.M., Chadban, S., Pilmore, H., Connolly, J., Buchler, M., Schena, F.P., Carreño, C.A., Dandavino, R., Cole, E. Transplantation (2003)
- Improved results using OKT3 as induction immunosuppression in renal allograft recipients with delayed graft function. Benvenisty, A.I., Cohen, D., Stegall, M.D., Hardy, M.A. Transplantation (1990)
- Effect of cyclosporine and delayed graft function on posttransplantation erythropoiesis. Besarab, A., Caro, J., Jarrell, B., Burke, J., Francos, G., Mallon, E., Karsch, R. Transplantation (1985)
- Pharmacokinetics of mycophenolic acid in renal transplant patients with delayed graft function. Shaw, L.M., Mick, R., Nowak, I., Korecka, M., Brayman, K.L. Journal of clinical pharmacology. (1998)
- Effective renal plasma flow calculated from a single blood sample following Technetium-99m mercaptoacetyltriglycine renal scan can predict delayed graft function in renal transplantation. Freedland, S.J., Mishkin, F., Shoskes, D.A. Techniques in urology. (2001)
- IP-10, apoptotic genes, and calcineurin subtype messenger RNA kinetics occurring in rat renal isografts from brain-dead donors. Kusaka, M., Fukami, N., Sasaki, H., Higuchi, T., Ishikawa, K., Shiroki, R., Hoshinaga, K. Transplant. Proc. (2005)
- Effect of cytokines and chemokines (TGF-beta, TNF-alpha, IL-6, IL-10, MCP-1, RANTES) gene polymorphisms in kidney recipients on posttransplantation outcome: influence of donor-recipient match. Lacha, J., Hribova, P., Kotsch, K., Brabcova, I., Bartosova, K., Volk, H.D., Vitko, S. Transplant. Proc. (2005)
- The contribution of adhesion molecule expression in donor kidney biopsies to early allograft dysfunction. Schwarz, C., Regele, H., Steininger, R., Hansmann, C., Mayer, G., Oberbauer, R. Transplantation (2001)
- Delayed graft function does not influence long-term outcome in cadaver kidney transplants without mismatch for HLA-DRB1. Ichikawa, Y., Hashimoto, M., Hanafusa, T., Kyo, M., Fujimoto, N., Matsuura, O., Takahara, S., Hayashi, R., Ihara, H., Ono, Y. Transpl. Int. (1995)
- Calcineurin-free protocols with basiliximab induction allow patients included in "old to old" programs achieve standard kidney transplant function. Emparan, C., Laukötter, M., Wolters, H., Dame, C., Heidenreich, S., Senninger, N. Transplant. Proc. (2003)
- Association between mannose-binding lectin levels and graft survival in kidney transplantation. Berger, S.P., Roos, A., Mallat, M.J., Fujita, T., de Fijter, J.W., Daha, M.R. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. (2005)
- A comparison of the effects of cyclosporine versus antilymphocyte globulin on delayed graft function in cadaver renal transplant recipients. Michael, H.J., Francos, G.C., Burke, J.F., Besarab, A., Moritz, M., Gillum, D., Jarrell, B. Transplantation (1989)
- Mycophenolate mofetil reduces the risk of acute rejection less in African-American than in Caucasian kidney recipients. Schweitzer, E.J., Yoon, S., Fink, J., Wiland, A., Anderson, L., Kuo, P.C., Lim, J.W., Johnson, L.B., Farney, A.C., Weir, M.R., Bartlett, S.T. Transplantation (1998)
- Use of anti-CD25 monoclonal antibody in combination with rapamycin to eliminate cyclosporine treatment during the induction phase of immunosuppression. Hong, J.C., Kahan, B.D. Transplantation (1999)
- Individualization of immediate posttransplant immunosuppression. The value of antilymphocyte globulin in patients with delayed graft function. Matas, A.J., Tellis, V.A., Quinn, T.A., Glicklich, D., Soberman, R., Veith, F.J. Transplantation (1988)
- Prostaglandin E1 reduces the risk of delayed graft function after cadaveric renal transplantation. Hollenbeck, M., Dinter, K., Torsello, G., Koch, M., Willers, R., Sandmann, W., Grabensee, B. Nephrol. Dial. Transplant. (1999)